Protease-activated receptor-2 ligands reveal orthosteric and allosteric mechanisms of receptor inhibition
Kennedy et al. report the pharmacological and in vivo profiling of two small molecule PAR2 inhibitors and an agonist. They conclude that while the small molecule agonist and one of the inhibitors bind to the orthosteric PAR2 binding site, the other inhibitor is a negative allosteric modulator, highl...
Saved in:
Main Authors: | Amanda J. Kennedy, Linda Sundström, Stefan Geschwindner, Eunice K. Y. Poon, Yuhong Jiang, Rongfeng Chen, Rob Cooke, Shawn Johnstone, Andrew Madin, Junxian Lim, Qingqi Liu, Rink-Jan Lohman, Anneli Nordqvist, Maria Fridén-Saxin, Wenzhen Yang, Dean G. Brown, David P. Fairlie, Niek Dekker |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/e6a39fb1480d47f3b76e5e7e14d4b26c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Full-length human GLP-1 receptor structure without orthosteric ligands
by: Fan Wu, et al.
Published: (2020) -
Orthosteric- versus allosteric-dependent activation of the GABAA receptor requires numerically distinct subunit level rearrangements
by: Jahanshah Amin, et al.
Published: (2017) -
Structure-guided design of pure orthosteric inhibitors of αIIbβ3 that prevent thrombosis but preserve hemostasis
by: Brian D. Adair, et al.
Published: (2020) -
Molecular tuning of farnesoid X receptor partial agonism
by: Daniel Merk, et al.
Published: (2019) -
Orthosteric binding of ρ-Da1a, a natural peptide of snake venom interacting selectively with the α1A-adrenoceptor.
by: Arhamatoulaye Maïga, et al.
Published: (2013)